These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 27210283

  • 1. Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Mambie A, Vuotto F, Poitrenaud D, Weyrich P, Cannesson O, Dessein R, Faure K, Guery B, Galpérine T.
    Med Mal Infect; 2016 Jun; 46(4):215-9. PubMed ID: 27210283
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Han SB, Lee SC, Lee SY, Jeong DC, Kang JH.
    BMC Infect Dis; 2015 Oct 13; 15():414. PubMed ID: 26464143
    [Abstract] [Full Text] [Related]

  • 4. Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Kernéis S, Valade S, Geri G, Compain F, Lavollay M, Rostane H, Carbonnelle E, Mainardi JL.
    Infect Dis (Lond); 2015 Oct 13; 47(11):789-95. PubMed ID: 26136072
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
    Espinar MJ, Miranda IM, Costa-de-Oliveira S, Rocha R, Rodrigues AG, Pina-Vaz C.
    PLoS One; 2015 Oct 13; 10(8):e0134737. PubMed ID: 26237422
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
    O'Kelly F, Kavanagh S, Manecksha R, Thornhill J, Fennell JP.
    BMC Infect Dis; 2016 Nov 03; 16(1):620. PubMed ID: 27806687
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L, Papa N, Aliyu SH, Dev H, Lawrentschuk N, Al-Hayek S.
    World J Urol; 2016 Jul 03; 34(7):1031-7. PubMed ID: 26511749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
    Araj GF, Jaber FA.
    J Med Liban; 2012 Jul 03; 60(3):142-7. PubMed ID: 23198454
    [Abstract] [Full Text] [Related]

  • 16. Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections.
    Yang YS, Ku CH, Lin JC, Shang ST, Chiu CH, Yeh KM, Lin CC, Chang FY.
    J Microbiol Immunol Infect; 2010 Jun 03; 43(3):194-9. PubMed ID: 21291846
    [Abstract] [Full Text] [Related]

  • 17. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D, Morris AJ, Dyet K, Bakker S, Heffernan H.
    N Z Med J; 2015 Mar 13; 128(1410):50-9. PubMed ID: 25829039
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.
    Joo EJ, Park DA, Lee NR, Moon SY, Choi JK, Ko JH, Peck KR.
    Eur J Clin Microbiol Infect Dis; 2017 Nov 13; 36(11):2093-2100. PubMed ID: 28643188
    [Abstract] [Full Text] [Related]

  • 20. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
    Sethaphanich N, Santanirand P, Rattanasiri S, Techasaensiri C, Chaisavaneeyakorn S, Apiwattanakul N.
    Pediatr Int; 2016 May 13; 58(5):338-46. PubMed ID: 26513341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.